FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SPY
2. USO
3. META
4. MSFT
5. MU
6. COST
7. IONS
8. CG
9. AVAV
10. SKHY

Go back to FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
Boston Scientific (NYSE: BSX) Delayed: 44.99 +0.18 (0.40%)
Previous Close $44.81    52 Week High $24.79 
Open $44.53    52 Week Low $15.67 
Day High $45.11    P/E N/A 
Day Low $44.10    EPS $-0.09 
Volume 12,400,553